Contact information
Simon Kyle
MA (First Class Hons.), PhD
Professor of Experimental and Clinical Sleep Research
- Programme Director, The Oxford Online Programme in Sleep Medicine
- Co-Director, Experimental and Clinical Sleep Medicine
- Honorary Member, Department of Psychiatry
- Senior Research Fellow, Somerville College
Sleep, sleep disorders and their treatment
I have specific research interests in the aetiology and management of sleep disturbance and the interaction between sleep disturbance and mental health.
My research is funded by The National Institute for Health and Care Research (NIHR) Oxford Health Biomedical Research Centre (BRC), Health Technology Assessment (HTA) Programme, Programme Grants for Applied Research (PGfAR), Efficacy and Mechanisms Evaluation (EME) Programme and the Wellcome Trust.
Websites
-
Kavli Institute for Nanoscience Discovery
Research centre
Key publications
-
Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial
KYLE S., (2023), The Lancet
-
The sleep-circadian interface: a window into mental disorders
Meyer N. et al, (2024), Proceedings of the National Academy of Sciences of USA
-
Biological and clinical insights from genetics of insomnia symptoms.
Lane JM. et al, (2019), Nat Genet, 51, 387 - 393
-
The effect of sleep restriction therapy for insomnia on sleep pressure and arousal: a randomised controlled mechanistic trial.
Maurer LF. et al, (2021), Sleep
-
A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application.
Espie CA. et al, (2012), Sleep, 35, 769 - 781
-
The effect of sleep continuity disruption on multimodal emotion processing and regulation: a laboratory-based, randomized, controlled experiment in good sleepers.
Reid M. et al, (2022), Journal of Sleep Research
-
Sleep and cognitive performance: cross-sectional associations in the UK Biobank.
Kyle SD. et al, (2017), Sleep Med, 38, 85 - 91
-
The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023.
Riemann D. et al, (2023), J Sleep Res, 32
Recent publications
-
Clinical effectiveness of DREAMS START (Dementia Related Manual for Sleep; Strategies for Relatives) versus usual care for people with dementia and their carers: a single-masked, phase 3, parallel-arm, superiority randomised controlled trial
KYLE S., (2024), The Lancet Healthy Longevity
-
Nurse-delivered sleep restriction therapy to improve insomnia disorder in primary care: the HABIT RCT
Kyle SD. et al, (2024), Health Technology Assessment, 1 - 107
-
The effect of single-component sleep restriction therapy on depressive symptoms: A systematic review and meta-analysis.
Tse KYK. et al, (2024), J Sleep Res
-
A systematic review of the performance of actigraphy in measuring sleep stages.
Yuan H. et al, (2024), J Sleep Res
-
Clinical and cost-effectiveness of DREAMS START (Dementia RElAted Manual for Sleep; STrAtegies for RelaTives) for people living with dementia and their carers: a study protocol for a parallel multicentre randomised controlled trial.
Rapaport P. et al, (2024), BMJ Open, 14
-
Self-supervised learning of accelerometer data provides new insights for sleep and its association with mortality
Yuan H. et al, (2024), npj Digital Medicine
-
The sleep-circadian interface: a window into mental disorders
Meyer N. et al, (2024), Proceedings of the National Academy of Sciences of USA
-
Nurse-delivered sleep restriction therapy in primary care for adults with insomnia disorder: a mixed-methods process evaluation.
Armstrong S. et al, (2024), Br J Gen Pract, 74, e34 - e40
-
Causal Association Between Subtypes of Excessive Daytime Sleepiness and Risk of Cardiovascular Diseases.
Goodman MO. et al, (2023), J Am Heart Assoc
-
The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023.
Riemann D. et al, (2023), J Sleep Res, 32